Building a Robust Investigator-Initiated Platform: The I-CARE Experience
Kirchgesner J, Stephane Nancey, Denis Franchimont(McGill University Health Centre), Georgios Michalopoulos, A Buisson, Piotr Eder(Poznan University of Medical Sciences), Livia Biancone(University of Rome Tor Vergata), Guillaume Pineton de Chambrun, Sohail Shariq, Jean‐Marie Reimund(Hôpital d'Hautepierre), Jimmy K Limdi, Peyrin-Biroulet L, Krasz S, Andrew Bell, Cañete F, Cossignani M, I‐CARE Collaborator Group: Jean-Marc Gornet, Marie Dewitte, Rimmer P, Viazis N, Baumann C, Holvoet T, Laurent Beaugerie, Sebastian S, Pierre Blanc, Bergemalm D, Rahier JF, Nikolaos Viazis, Kumar A., Goren I, Beaugerie L, Girod P, Sheridan J, Thut J, Laurent Peyrin-Biroulet, Caron B, Konstantinos Karmiris, Xavier Hebuterne, Avedano L, Dias S, Rousseau H, Uzzan M, Franco Armelao(Ospedale Santa Chiara), Weimers P, Baert F, Sebastian Shaji, Farkas K, Zagórowicz E, Aurélien Amiot, Zia Mazhar
Cineca Institutional Research Information System (Tor Vergata University)
January 1, 2026
Cited by 0
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k